CG
AKTS

Caprock Group’s Aktis Oncology AKTS Stock Holding History

Caprock Group’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Buy
+9,908
New +$203K 0.01% 1010

Other funds holding AKTS

TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Caprock Group's AKTS Position: Q2 2026 in Review

Caprock Group opened a new position in Aktis Oncology (AKTS) in Q2 2026: 9,908 shares worth $319K. The stake represents 0.01% of the portfolio and ranks #1010 among its holdings.

21 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Caprock Group held 9,908 shares of Aktis Oncology worth $319K as of Q2 2026.
  • Aktis Oncology was a new Caprock Group position in Q2 2026.
  • Aktis Oncology made up 0.01% of Caprock Group's portfolio in Q2 2026, its #1010 holding.
  • 21 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.